MC1438A1 - Derives d'oxadiazolopyrimidine - Google Patents

Derives d'oxadiazolopyrimidine

Info

Publication number
MC1438A1
MC1438A1 MC811567A MC1567A MC1438A1 MC 1438 A1 MC1438 A1 MC 1438A1 MC 811567 A MC811567 A MC 811567A MC 1567 A MC1567 A MC 1567A MC 1438 A1 MC1438 A1 MC 1438A1
Authority
MC
Monaco
Prior art keywords
dihydro
carbamate
oxo
process according
oxadiazolo
Prior art date
Application number
MC811567A
Other languages
English (en)
French (fr)
Inventor
Urs Hengartner
Jean Claude Mueller
Henri Ramuz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1438A1 publication Critical patent/MC1438A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MC811567A 1980-12-19 1981-12-18 Derives d'oxadiazolopyrimidine MC1438A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH941080 1980-12-19
CH635081 1981-10-02

Publications (1)

Publication Number Publication Date
MC1438A1 true MC1438A1 (fr) 1982-12-06

Family

ID=25699419

Family Applications (1)

Application Number Title Priority Date Filing Date
MC811567A MC1438A1 (fr) 1980-12-19 1981-12-18 Derives d'oxadiazolopyrimidine

Country Status (23)

Country Link
US (2) US4410698A (OSRAM)
EP (1) EP0054866B1 (OSRAM)
KR (1) KR880001636B1 (OSRAM)
AR (1) AR229169A1 (OSRAM)
AT (1) ATE14734T1 (OSRAM)
AU (1) AU545324B2 (OSRAM)
BR (1) BR8108269A (OSRAM)
CA (1) CA1162538A (OSRAM)
CS (1) CS226738B2 (OSRAM)
DE (1) DE3171744D1 (OSRAM)
DK (1) DK148826C (OSRAM)
ES (1) ES8304125A1 (OSRAM)
FI (1) FI71153C (OSRAM)
GR (1) GR76969B (OSRAM)
HU (1) HU183744B (OSRAM)
IE (1) IE51800B1 (OSRAM)
IL (1) IL64524A (OSRAM)
MC (1) MC1438A1 (OSRAM)
NO (1) NO158422C (OSRAM)
NZ (1) NZ199250A (OSRAM)
PH (1) PH17300A (OSRAM)
PT (1) PT74153B (OSRAM)
ZW (1) ZW28581A1 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK148826C (da) * 1980-12-19 1986-03-24 Hoffmann La Roche Analogifremgangsmaade til fremstilling af oxadiazolopyrimidinderivater eller salte deraf med baser og pyrimidinderivat til anvendelse som mellemprodukt ved denne fremgangsmaade
CH649291A5 (de) * 1982-03-16 1985-05-15 Hoffmann La Roche Dicarbamate.
EP0187854A4 (en) * 1984-07-13 1987-01-22 Gail S Bazzano SUBSTITUTED PYRIMIDINE OXIDES USEFUL FOR PROMOTING HAIR GROWTH.
LU86959A1 (fr) * 1987-07-31 1989-03-08 Oreal Nouveaux derives d'ureylene triamino-2,4,6 pyrimidine oxyde-3,leur preparation et leur utilisation en cosmetique et dermopharmacie
WO1998004531A1 (en) * 1996-07-26 1998-02-05 Ciba Specialty Chemicals Holding Inc. Curable mixtures based on epoxy resins comprising imidazoles
CN117946133B (zh) * 2024-01-05 2024-08-06 南京理工大学 一种5-(4-氨基-1,2,5-噁二唑-3-基)[1,2,5]噁二唑并[3,4-d]嘧啶-7-胺及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH638216A5 (de) * 1977-02-04 1983-09-15 Hoffmann La Roche Oxadiazolopyrimidin-deriate.
CH638215A5 (de) * 1977-02-04 1983-09-15 Hoffmann La Roche Oxadiazolopyrimidin-derivate.
CA1103245A (en) * 1978-07-21 1981-06-16 Jean-Claude Muller Process for the manufacture of novel oxadiazolopyrimidine derivatives
NZ190915A (en) * 1978-07-31 1984-07-31 Hoffmann La Roche Oxadiazolotriazine derivatives and pharmaceutical compositions
DK148826C (da) * 1980-12-19 1986-03-24 Hoffmann La Roche Analogifremgangsmaade til fremstilling af oxadiazolopyrimidinderivater eller salte deraf med baser og pyrimidinderivat til anvendelse som mellemprodukt ved denne fremgangsmaade

Also Published As

Publication number Publication date
HU183744B (en) 1984-05-28
IE51800B1 (en) 1987-04-01
PT74153A (en) 1982-01-01
IE812990L (en) 1982-06-19
EP0054866A2 (de) 1982-06-30
DK504881A (da) 1982-06-20
FI71153C (fi) 1986-11-24
ES508152A0 (es) 1983-02-16
GR76969B (OSRAM) 1984-09-04
CS226738B2 (en) 1984-04-16
DE3171744D1 (en) 1985-09-12
US4360521A (en) 1982-11-23
EP0054866B1 (de) 1985-08-07
NO158422B (no) 1988-05-30
CA1162538A (en) 1984-02-21
NZ199250A (en) 1984-04-27
DK148826C (da) 1986-03-24
IL64524A (en) 1985-05-31
ATE14734T1 (de) 1985-08-15
FI71153B (fi) 1986-08-14
AU7846481A (en) 1982-06-24
KR880001636B1 (ko) 1988-09-03
PH17300A (en) 1984-07-18
IL64524A0 (en) 1982-03-31
AR229169A1 (es) 1983-06-30
ES8304125A1 (es) 1983-02-16
US4410698A (en) 1983-10-18
FI814048L (fi) 1982-06-20
ZW28581A1 (en) 1982-08-11
DK148826B (da) 1985-10-14
EP0054866A3 (en) 1982-09-01
PT74153B (en) 1984-01-05
NO814359L (no) 1982-06-21
BR8108269A (pt) 1982-10-05
AU545324B2 (en) 1985-07-11
NO158422C (no) 1988-09-07

Similar Documents

Publication Publication Date Title
MC1213A1 (fr) Derives imidazoliques utiles comme medicaments
FR2654725A1 (fr) Nouveaux derives de l'isoindolone, leur preparation et les compositions pharmaceutiques qui les contiennent.
EP0003383B1 (fr) Dérivés de 4-amino-3-sulfonamido-pyridine
FR2694004A1 (fr) Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
FR2698873A1 (fr) Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.
EP0839149B9 (fr) Derives de la galanthamine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2720396A1 (fr) Nouveaux N-pyridyl carboxamides et dérivés leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
EP0507696A1 (fr) Antihistaminiques non sédatifs, dérivés de benzimidazole, leur procédé de préparation et leur utilisation en tant que médicaments.
FR2561647A1 (fr) Derives de 1-(hydroxymethyl)-1,6,7,11b-tetrahydro-2h,4h-(1,3)-oxazino- ou -thiazino(4,3,a)isoquinoleine, procede pour leur preparation et compositions pharmaceutiques les contenant
MC1628A1 (fr) Nouvelles triazines et leur preparation
FR2623806A1 (fr) Esters d'acides 3,6-dihydro-1,5(2h)-pyrimidinecarboxyliques a action therapeutique
BE898383A (fr) Pyrazoloquinoleines substituees particulieres, procede pour leur preparation, preparations pharmaceutiques contenant ces composes et leur application therapeutique.
FR2727680A1 (fr) Nouveaux derives de 5-pyrrolyl-6-halogeno-2- pyridylmethylsufinylbenzimidazole
MC1438A1 (fr) Derives d'oxadiazolopyrimidine
MC1771A1 (fr) Derives de benzimidazole
FR2539417A1 (fr) Nouveaux pyrrolo-1, 2 heterocycles, leur preparation et les medicaments qui les contiennent
EP0412899B1 (fr) Dérivés d'oxazolo pyridines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
MC1650A1 (fr) Derives de l'imidazole
EP0205280A2 (en) Tetrahydroimidazoquinazolinone cardiac stimulants
FR2623502A1 (fr) Esters d'acide 3-oxo-1,2,4-triazolo (4,3-a)pyrimidine-6-carboxylique a action therapeutique
FR2528431A1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
CH644858A5 (fr) Derives du (pyridyl-2)-2 tetrahydrothiophene, leur preparation et les medicaments qui les contiennent.
MC1186A1 (fr) Derives de quinazoline
BE897473A (fr) Nouveaux alcaloides de l'ergot de seigle leur preparation et leur utilisation comme medicaments
BE898403A (fr) Nouveaux derives d'ethene-diamine et de guanidine.

Legal Events

Date Code Title Description
YP Annual fee paid